How Much Does Viagra Cost in Arkansas in 2026?

Brand Viagra vs. Generic Sildenafil: The Price Gap in Arkansas

Pfizer's brand-name Viagra still carries a wholesale acquisition cost near $700 for a 30-tablet supply, a figure that has barely moved since the drug's FDA approval in 1998. Almost nobody pays that number. Generic sildenafil, available since Pfizer's patent expired in 2017, averages around $50 per month at Arkansas retail pharmacies.

The price difference is straightforward: generics contain the same active ingredient at the same dose, manufactured under the same FDA bioequivalence standards, but without the brand premium. Teva, Greenstone (Pfizer's own authorized generic), and several other manufacturers supply the Arkansas market. Pharmacy-to-pharmacy variation exists. A Walmart in Little Rock may charge $4 to $9 for a small quantity through its discount generics program, while an independent pharmacy in Jonesboro might price 30 tablets at $55 to $65 without a discount card. GoodRx and RxSaver coupons typically bring the out-of-pocket cost to $8 to $30 for 30 tablets of sildenafil 20 mg (the pulmonary arterial hypertension strength, often prescribed off-label in erectile dysfunction at higher tablet counts).

One thing worth understanding: sildenafil 20 mg tablets (approved for pulmonary arterial hypertension under the brand name Revatio) are frequently prescribed for ED because pharmacies price them lower than sildenafil 50 mg or 100 mg tablets. A prescriber may write for three 20 mg tablets per dose. The pharmacology is identical [1].

Arkansas Medicaid Coverage for Sildenafil

Arkansas Medicaid does cover sildenafil for erectile dysfunction, but the program requires prior authorization. The prescriber must document a diagnosis of ED (ICD-10 N52.x) and confirm the absence of contraindications, particularly concurrent nitrate therapy. Medicaid will generally approve generic sildenafil rather than brand Viagra.

Quantity limits apply. Arkansas Medicaid's preferred drug list typically allows six to eight doses per month, matching the clinical pattern described in the original Goldstein et al. trial in the New England Journal of Medicine (N=532), where patients used sildenafil on an as-needed basis rather than daily [1]. Approval duration is usually 12 months before reauthorization.

For men enrolled in Arkansas's Medicaid expansion population (ARHOME, the state's Section 1115 waiver program), the same PA process applies. Co-pays for preferred generics are typically $1 to $4 for Medicaid beneficiaries. If the PA is denied, the prescriber can file an appeal; common denial reasons include missing documentation or formulary-preferred alternatives not yet tried.

The PA process usually takes 24 to 72 hours when submitted electronically through the pharmacy benefits manager. Paper faxes take longer. Patients filling at chain pharmacies (CVS, Walgreens, Walmart) in Arkansas generally see faster electronic PA turnaround than those using smaller independents without integrated e-PA systems.

Insurance Coverage Across Arkansas Commercial Plans

Most employer-sponsored and ACA marketplace plans sold in Arkansas place generic sildenafil on their formularies, though coverage varies by plan tier and insurer. Blue Cross Blue Shield of Arkansas, the state's largest commercial insurer, covers generic sildenafil on its preferred generic tier (Tier 1) with quantity limits of six to twelve tablets per month on most plans. QualChoice, another major Arkansas carrier, follows a similar pattern.

Brand Viagra, by contrast, sits on Tier 3 (non-preferred brand) or is excluded entirely on many plans. Co-pays for Tier 3 drugs in Arkansas marketplace plans averaged $45 to $80 per prescription in 2025 plan filings, making generic sildenafil at a $10 to $15 Tier 1 co-pay the obvious financial choice.

Self-insured employer plans (common among Arkansas's larger employers like Walmart, Tyson Foods, and Dillard's) set their own formulary rules. Some exclude ED medications entirely. Others cover sildenafil but impose step therapy or limit coverage to specific diagnoses (e.g., ED secondary to prostatectomy or diabetes). Checking the plan's Summary of Benefits and Coverage document or calling the pharmacy benefits manager directly is the fastest way to confirm.

A 2020 analysis published in the Journal of Sexual Medicine found that roughly 75% of commercially insured men with ED prescriptions faced some form of utilization management (prior authorization, step therapy, or quantity limits) [2]. Arkansas mirrors that national trend.

Compounded Sildenafil in Arkansas: Legal, Regulated, and Cheaper

Compounded sildenafil is legal in Arkansas when dispensed by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. These pharmacies prepare custom formulations (sublingual troches, flavored suspensions, or combination tablets with other active ingredients) that are not available as FDA-approved manufactured products.

Pricing runs approximately $30 per month for compounded sildenafil troches or tablets. That is 40% below the average generic retail price. The trade-off: compounded drugs are not FDA-approved finished products, so they lack the same lot-to-lot consistency testing that manufactured generics undergo. The Arkansas State Board of Pharmacy oversees 503A pharmacies and requires compliance with USP 795 and USP 797 standards for non-sterile and sterile compounding, respectively.

Telehealth platforms that ship compounded sildenafil into Arkansas must use pharmacies licensed in the state. Several national telehealth-to-compounding pipelines operate in Arkansas, including Hims, Ro, and smaller niche providers. The FDA's guidance on compounding clarifies that 503A pharmacies may compound drugs that are essentially copies of commercially available products only when the prescriber documents a clinical difference for the individual patient (e.g., dye allergy, swallowing difficulty, need for a non-standard dose) [3].

Dr. John P. Mulhall, Director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan Kettering, has noted: "Compounded sildenafil fills a real clinical gap for patients who need dose forms the manufactured product doesn't offer, but patients should verify their pharmacy holds proper state licensure."

Telehealth Access to Viagra Prescriptions in Arkansas

Arkansas permits telehealth prescribing of sildenafil. The state followed the broader post-pandemic regulatory trend: the Arkansas State Medical Board allows prescribers to establish a patient-provider relationship via synchronous audio-video visit and then prescribe Schedule VI (non-controlled) medications, which includes sildenafil.

The process is simple. A patient completes a health intake, has a video or live-chat consultation with a licensed prescriber, and receives a prescription sent electronically to a pharmacy of their choice. Arkansas does not require an in-person visit before an initial sildenafil prescription, though the prescriber must perform an adequate clinical evaluation. That evaluation should include screening for cardiovascular risk factors, current medications (especially nitrates and alpha-blockers), and hepatic or renal impairment, consistent with FDA labeling [4].

Multiple telehealth platforms serve Arkansas residents. Pricing models differ. Some charge a flat consultation fee ($15 to $50) plus the pharmacy cost of the medication. Others bundle the consultation, medication, and shipping into a single monthly subscription ($20 to $60 per month for generic sildenafil). Patients using insurance can have the telehealth prescriber send the prescription to their preferred in-network pharmacy instead of using the platform's bundled pharmacy.

Discount Programs and Savings Cards Available in Arkansas

Several pathways reduce out-of-pocket cost beyond insurance. The most accessible options for Arkansas residents:

Manufacturer savings cards. Pfizer offers a savings card for brand Viagra that reduces co-pays for commercially insured patients. The card is not valid for Medicare, Medicaid, or Tricare beneficiaries. Generic manufacturers (including Teva) periodically offer similar co-pay assistance, though these programs change frequently.

Pharmacy discount programs. Walmart's $4/$10 generic program includes sildenafil 20 mg at select Arkansas locations. Costco (the Bentonville and Little Rock locations require no membership for pharmacy access under Arkansas law) prices sildenafil competitively, often under $15 for 30 tablets with a coupon.

State assistance. Arkansas does not operate a state-specific pharmaceutical assistance program for ED medications. However, the ARHealthConnect portal can help uninsured residents find federally qualified health centers (FQHCs) that offer sliding-scale fee services, including prescriptions through 340B drug pricing. FQHC pharmacies in Arkansas participating in 340B can dispense sildenafil at significant discounts.

Veterans. The VA Central Arkansas Healthcare System (with facilities in Little Rock and North Little Rock) covers sildenafil for service-connected ED. The VA national formulary includes sildenafil, and co-pays for veterans without service-connected conditions are set by VA priority group, typically $5 to $11 for a 30-day supply [5].

A 2022 JAMA Internal Medicine study reported that out-of-pocket spending on PDE5 inhibitors varied by more than 10-fold across U.S. pharmacies for the same drug and quantity, underscoring the importance of price-shopping even within a single state like Arkansas [6].

How Sildenafil Pricing Compares to Other ED Drugs in Arkansas

Sildenafil is the least expensive PDE5 inhibitor available in Arkansas. Generic tadalafil (Cialis) has dropped to $30 to $70 per month at most Arkansas pharmacies, making it competitive. The clinical difference: tadalafil's 17.5-hour half-life supports daily low-dose (2.5 mg or 5 mg) use or as-needed dosing with a longer activity window, while sildenafil's 4-hour duration is strictly as-needed.

Avanafil (Stendra) remains brand-only and costs $400 or more per month. Vardenafil (generic Levitra) falls between sildenafil and tadalafil in price. For most Arkansas patients optimizing on cost, generic sildenafil or generic tadalafil are the practical choices.

The American Urological Association's 2018 guideline on ED recommends PDE5 inhibitors as first-line pharmacotherapy and does not preference one agent over another, stating that selection should be based on "patient preference, cost, ease of use, and side-effect profile" [7].

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a lead author on AUA ED guidelines, has stated: "All four PDE5 inhibitors have comparable efficacy rates in the 60 to 70 percent range. Cost and dosing convenience are legitimate tie-breakers."

Filling a Prescription: What Arkansas Patients Should Know

Sildenafil requires a prescription in Arkansas. No pharmacy in the state can legally dispense it over the counter. The prescription can come from any licensed prescriber with prescriptive authority (MD, DO, NP, PA) practicing within their scope under Arkansas law.

New patients should expect the prescriber to ask about cardiac history, blood pressure, current medications, and prior PDE5 inhibitor use. The FDA label carries a black-box-level warning against concurrent use with organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to the risk of severe hypotension [4]. Alpha-blocker interactions also require dose adjustment.

Standard dosing is 50 mg taken 30 to 60 minutes before sexual activity, adjustable to 25 mg or 100 mg based on efficacy and tolerability. The maximum is one dose per 24-hour period. Food (especially high-fat meals) delays absorption by approximately 60 minutes and reduces peak plasma concentration by 29%, per pharmacokinetic data in the original FDA review [4]. Taking sildenafil on an empty stomach or after a light meal produces faster onset.

For patients who have tried sildenafil without adequate response, the prescriber should verify proper dosing technique (timing, food effects, adequate sexual stimulation) before escalating therapy. The Goldstein et al. trial demonstrated that 69% of all attempts at intercourse were successful with sildenafil versus 22% with placebo (P<0.001), but non-response can reflect underlying vascular disease severity, hypogonadism, or psychogenic factors that require separate evaluation [1].